Risk  	Risk  	 NN	B-NP
evaluation  	evaluation  	 NN	I-NP
and  	and  	 CC	O
mitigation  	mitigation  	 JJ	B-NP
strategies 	strategies 	 NNS	I-NP
:  	:  	 :	O
impact  	impact  	 NN	O
on  	on  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers 	providers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
health  	health  	 NN	B-NP
systems  	systems  	 NNS	I-NP
To  	To  	 TO	O
describe  	describe  	 VB	O
the  	the  	 DT	O
impetus  	impetus  	 NN	O
for  	for  	 IN	O
and  	and  	 CC	O
evolution 	evolution 	 NN	B-NP
,  	,  	 ,	O
components 	components 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
potential  	potential  	 JJ	B-NP
impact  	impact  	 NN	I-NP
on  	on  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers 	providers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
health  	health  	 NN	B-NP
systems  	systems  	 NNS	I-NP
of  	of  	 IN	I-NP
risk  	risk  	 NN	I-NP
evaluation  	evaluation  	 NN	I-NP
and  	and  	 CC	O
mitigation  	mitigation  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
( 	( 	 -LRB-	O
REMS 	REMS 	 NNP	B-NP
)  	)  	 -RRB-	O
required  	required  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Food  	Food  	 NNP	B-NP
and  	and  	 CC	I-NP
Drug  	Drug  	 NNP	I-NP
Administration  	Administration  	 NNP	I-NP
( 	( 	 -LRB-	O
FDA 	FDA 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
managing  	managing  	 VBG	O
known  	known  	 VBN	O
or  	or  	 CC	O
potential  	potential  	 JJ	B-NP
serious  	serious  	 JJ	I-NP
drug  	drug  	 NN	I-NP
risks 	risks 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
2006  	2006  	 CD	O
report  	report  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
Institute  	Institute  	 NNP	O
of  	of  	 IN	O
Medicine  	Medicine  	 NNP	O
criticizing  	criticizing  	 VBD	B-NP
FDA  	FDA  	 NNP	I-NP
for  	for  	 IN	I-NP
drug  	drug  	 NN	I-NP
withdrawals  	withdrawals  	 NNS	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
safety  	safety  	 NN	O
problems  	problems  	 NNS	O
provided  	provided  	 VBD	O
the  	the  	 DT	O
impetus  	impetus  	 NN	O
for  	for  	 IN	O
FDA  	FDA  	 NNP	B-NP
to  	to  	 TO	O
enhance  	enhance  	 VB	O
postmarketing  	postmarketing  	 JJ	B-NP
surveillance  	surveillance  	 NN	I-NP
and  	and  	 CC	O
to  	to  	 TO	O
require  	require  	 VB	O
REMS  	REMS  	 NNP	B-NP
for  	for  	 IN	O
medications  	medications  	 NN	O
with  	with  	 IN	O
actual  	actual  	 JJ	O
or  	or  	 CC	O
potential  	potential  	 JJ	B-NP
safety  	safety  	 NN	I-NP
concerns 	concerns 	 NNS	I-NP
.  	.  	 .	O
Components  	Components  	 NNS	O
of  	of  	 IN	O
REMS  	REMS  	 NNP	B-NP
may  	may  	 MD	O
include  	include  	 VB	O
medication  	medication  	 JJ	B-NP
guides 	guides 	 NNS	I-NP
,  	,  	 ,	O
patient  	patient  	 JJ	O
package  	package  	 NN	B-NP
inserts 	inserts 	 NNS	I-NP
,  	,  	 ,	O
communication  	communication  	 NN	B-NP
plans  	plans  	 NNS	I-NP
for  	for  	 IN	I-NP
health  	health  	 NN	I-NP
care  	care  	 NN	I-NP
providers 	providers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
elements  	elements  	 NNS	O
to  	to  	 TO	O
ensure  	ensure  	 VB	O
safe  	safe  	 JJ	O
use  	use  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
special  	special  	 JJ	O
training  	training  	 NN	O
or  	or  	 CC	O
certification  	certification  	 NN	B-NP
for  	for  	 IN	O
prescribing  	prescribing  	 NN	O
or  	or  	 CC	O
dispensing 	dispensing 	 NN	O
,  	,  	 ,	O
dispensing  	dispensing  	 VBG	O
only  	only  	 RB	O
under  	under  	 IN	O
certain  	certain  	 JJ	O
circumstances 	circumstances 	 NNS	O
,  	,  	 ,	O
special  	special  	 JJ	O
monitoring 	monitoring 	 NN	O
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
patient  	patient  	 JJ	O
registries 	registries 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
increases  	increases  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
drugs  	drugs  	 NNS	O
with  	with  	 IN	O
REMS  	REMS  	 NNP	B-NP
requirements 	requirements 	 NNS	I-NP
,  	,  	 ,	O
MedWatch  	MedWatch  	 JJ	B-NP
alerts 	alerts 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
new  	new  	 JJ	O
Sentinel  	Sentinel  	 NNP	B-NP
Initiative  	Initiative  	 NNP	I-NP
reflect  	reflect  	 VBP	O
FDA 	FDA 	 NNP	O
's  	's  	 POS	O
commitment  	commitment  	 NN	O
to  	to  	 TO	O
drug  	drug  	 NN	B-NP
safety 	safety 	 NN	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
overwhelmed  	overwhelmed  	 VBN	O
by  	by  	 IN	O
information  	information  	 NN	O
about  	about  	 IN	O
drugs  	drugs  	 NNS	O
with  	with  	 IN	O
REMS  	REMS  	 NNP	B-NP
requirements 	requirements 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
could  	could  	 MD	O
deter  	deter  	 VB	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
potentially  	potentially  	 RB	O
beneficial  	beneficial  	 JJ	O
therapies 	therapies 	 NNS	O
.  	.  	 .	O
Pharmacists  	Pharmacists  	 NNP	O
can  	can  	 MD	O
help  	help  	 VB	O
patients  	patients  	 NNS	O
weigh  	weigh  	 VBP	O
the  	the  	 DT	O
risks  	risks  	 NNS	O
and  	and  	 CC	O
benefits  	benefits  	 NNS	O
of  	of  	 IN	O
drug  	drug  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Pharmacists 	Pharmacists 	 NNP	O
,  	,  	 ,	O
other  	other  	 JJ	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers 	providers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
health  	health  	 NN	B-NP
systems  	systems  	 NNS	I-NP
may  	may  	 MD	O
find  	find  	 VB	O
REMS  	REMS  	 JJ	B-NP
requirements  	requirements  	 NNS	I-NP
challenging 	challenging 	 VBG	O
,  	,  	 ,	O
but  	but  	 CC	O
FDA  	FDA  	 NNP	B-NP
is  	is  	 VBZ	O
cognizant  	cognizant  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
need  	need  	 NN	O
to  	to  	 TO	O
balance  	balance  	 VB	O
the  	the  	 DT	O
goals  	goals  	 NNS	O
of  	of  	 IN	O
ensuring  	ensuring  	 VBG	B-NP
drug  	drug  	 NN	I-NP
safety  	safety  	 NN	I-NP
and  	and  	 CC	O
providing  	providing  	 VBG	O
patient  	patient  	 JJ	O
access  	access  	 NN	O
to  	to  	 TO	O
drugs  	drugs  	 NNS	O
without  	without  	 IN	O
placing  	placing  	 VBG	O
an  	an  	 DT	O
undue  	undue  	 JJ	O
burden  	burden  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
health  	health  	 NN	B-NP
system 	system 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
improving  	improving  	 VBG	B-NP
drug  	drug  	 NN	I-NP
safety  	safety  	 NN	I-NP
is  	is  	 VBZ	O
sought  	sought  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
FDA 	FDA 	 NNP	B-NP
,  	,  	 ,	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers 	providers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
health  	health  	 NN	B-NP
systems  	systems  	 NNS	I-NP
alike 	alike 	 RB	O
.  	.  	 .	O
Collaboration  	Collaboration  	 NN	B-NP
among  	among  	 IN	O
health  	health  	 NN	B-NP
care  	care  	 NN	I-NP
providers  	providers  	 NNS	I-NP
may  	may  	 MD	O
provide  	provide  	 VB	O
efficiencies  	efficiencies  	 NNS	O
in  	in  	 IN	O
meeting  	meeting  	 VBG	B-NP
FDA  	FDA  	 NNP	I-NP
REMS  	REMS  	 NNP	I-NP
requirements 	requirements 	 NNS	I-NP
.  	.  	 .	O
